The global preclinical imaging market was valued at USD 1.0 billion in 2025 and is projected to grow from USD 1.1 billion in 2026 to USD 1.6 billion by 2033, registering a CAGR of 5.6% from 2026 to 2033. North America dominated the market in 2025, accounting for 46.4% of global revenue. Market growth is being driven by increasing investments in drug discovery and development, the rising...

Revolutionizing Preclinical Imaging: AI-Driven Insights Shaping Drug Discovery 2025-2035 Discover how AI is transforming preclinical research and accelerating your drug development pipeline. Download our exclusive 2025-2035 forecast report now! The landscape of drug development is undergoing a seismic shift, driven by advancements in preclinical imaging and the transformative power of...

The global preclinical imaging market is experiencing steady growth, driven by rising investments in pharmaceutical research and development (R&D), increasing demand for advanced drug discovery tools, and continuous technological advancements in biomedical imaging. According to Grand View Research, the market is expanding as pharmaceutical companies, biotechnology firms, and research...

A researcher tracking how immune cells behave inside a tumor used to have one option: euthanize the animal and section the tissue. Today, that same researcher can watch it happen in real time, in a living mouse, using a PET scanner scaled down to laboratory size. That shift — from destructive, single-timepoint biology to non-invasive, longitudinal biology — is the entire reason the...